Figure 3

Body weight, blood pressure, and renal functions in aristolochic acid (AA)-induced CKD model mice. (A) Body weight changes in vehicle and AA groups. (B) Systolic blood pressure in vehicle and AA groups at 0, 4, or 8 weeks after treatment. (C) Plasma creatinine level, (D) BUN level, (E) urinary albumin excretion, and (F) creatinine clearance were measured at 8 weeks after treatment in vehicle and AA groups. Values are expressed as mean ± standard error of the mean (5–6 mice per group). P values, versus vehicle: #P < 0.05; ##P < 0.01; ###P < 0.001. CKD, chronic kidney disease; BP, blood pressure; BUN, blood urea nitrogen.